Guggenhime Andrew
Vaxcyte, Inc. · PRESIDENT AND CFO
Guggenhime Andrew is listed in filings as PRESIDENT AND CFO at Vaxcyte, Inc.. This profile follows SEC Form 4 activity through Mar 11, 2026, including sale activity. Recent filings connect the profile to Vaxcyte, Inc. (PCVX) and Caribou Biosciences, Inc. (CRBU). The current snapshot covers public activity from Oct 22, 2024 to Mar 11, 2026. Reported amounts are shown as $60.6K to $55.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $458k5.3k shares | SellJan 21, 2025 | $86.08 | $56.74 | |
| $174k2k shares | SellJan 21, 2025 | $87.25 | $56.74 | |
| $60k683 shares | SellJan 21, 2025 | $87.70 | $56.74 | |
| $299k3.4k shares | SellDec 18, 2024 | $88.70 | $56.74 | |
| $282k3.2k shares | SellDec 18, 2024 | $89.31 | $56.74 | |
| $104k1.2k shares | SellDec 18, 2024 | $87.26 | $56.74 | |
| $25k280 shares | SellDec 18, 2024 | $90.24 | $56.74 | |
| $523k6.1k shares | SellNov 18, 2024 | $85.60 | $56.74 | |
| $152k1.8k shares | SellNov 18, 2024 | $86.49 | $56.74 | |
| $11k132 shares | SellNov 18, 2024 | $87.05 | $56.74 | |
| $4M36.1k shares | SellOct 18, 2024 | $115.26 | $56.74 | |
| $684k5.9k shares | SellOct 18, 2024 | $116.19 | $56.74 |